(98 : 2) as eluent afforded the protected p-coumaryl coumarate
(33, 89.9 mg, 0.175 mmol). An aliquot of the latter (87.2 mg,
0.17 mmol) was dissolved in dry THF (2 cm3), with piperazine
(146 mg, 1.7 mmol in 2 cm3 dry THF) added at room temperature
under N2. Following stirring for 2 h, the mixture was diluted with
CHCl3 (3 cm3) and EtOAc (25 cm3), with the whole washed with
sat. NH4Cl solution (8 × 15 cm3) to remove excess piperazine.
The organic solubles were dried (Na2SO4), concentrated in vacuo
and subjected to column chromatography using deactivated silica
gel (pre-treatment with EtOH–HOAc, 99 : 1) and CHCl3–EtOAc
(1 : 1) as eluent, to afford p-coumaryl coumarate (32, 48.2 mg,
0.16 mmol, 80% yield) as a pale yellow solid. dH (300 MHz;
Me2CO-d6; Me4Si) 7.66 (1 H, d, J11,12 16.0 Hz, 12-H), 7.57
(2 H, d, J14,15/17,18 7.3 Hz, 14-H/18-H), 7.35 (2 H, d, J2,3/5,6 7.0 Hz,
2-H/6-H), 6.91 (2 H, d, J14,15/17,18 7.3 Hz, 15-H/17-H), 6.83
(2 H, d, J2,3/5,6 7.0 Hz, 3-H/5-H), 6.68 (1 H, d, J7,8 15.9 Hz,
7-H), 6.40 (1 H, d, J11,12 16.0 Hz, 11-H), 6.24 (1 H, m, H8), 4.79
(2 H, d, J8,9 6.5 Hz, 9-H); dC (75 MHz; Me2CO-d6) 167.38 (C-10),
160.64 (C-16), 158.45 (C-4), 145.55 (C-12), 134.71 (C-7), 131.04
(C-14/C-18), 129.02 (C-1), 128.89 (C-2/C-6), 127.05 (C-13),
121.54 (C-8), 116.76 (C-15/C-17), 116.38 (C-3/C-5), 115.58
(C-11), 65.64 (C-9); m/z (ESI) 294.7 (14%, M − 1−), 177.1 (26),
163.0 (100, p-coumarate), 145.1 (16), 119.0 (43, p-coumarate −
CO2). NMR assignments were confirmed by exhaustive 2D NMR
experiments (300 MHz 1H–1H COSY, 500 MHz HMBC and
HMQC in a Varian Inova 500 spectrometer).
with EtOAc (30 cm3). The organic solubles were washed with 3%
aqueous HCl (2 × 15 cm3), sat. NH4Cl solution (2 × 15 cm3), brine
(15 cm3), dried (Na2SO4) and concentrated in vacuo. The resulting
product was fractionated by pTLC using hexane–Me2CO (2 : 1)
as eluent to afford p-coumaryl acetate (27, 3.79 mg, 19.7 lmol,
31.5% yield). dH (300 MHz; Me2CO-d6) 7.32 (2 H, d, J2,3/5,6 8.4 Hz,
2-H/6-H), 6.82 (2 H, d, J2,3/5,6 8.4 Hz, 3-H/5-H), 6.62 (1 H, d, J7,8
15.9 Hz, 7-H), 6.16 (1 H, dt, J7,8 15.9, J8,9 6.6 Hz, 8-H), 4.66 (2 H,
d, J8,9 6.6 Hz, 9-H), 2.02 (3 H, s, OAc).
[9-3H]-p-Coumaryl acetate (27). [9-3H]-p-Coumaryl alcohol
(22, 15.0 mg, 100 lmol) was dissolved in pyridine (200 mm3)
and Ac2O (200 mm3) containing a catalytic amount of DMAP as
above, and left unstirred for 4 h. The reaction mixture was added to
Et2O (50 cm3), then extracted with 3% aqueous HCl (3 × 15 cm3),
sat. NH4Cl solution (2 × 15 cm3), brine (2 × 15 cm3), and dried
(Na2SO4) before concentrationin vacuo. The resulting material was
dissolved in pyrrolidine (500 mm3) and left unstirred for 5 min,
with the whole then added to Et2O and washed with 3% aqueous
HCl (20 cm3), sat. NH4Cl solution (20 cm3), brine (20 cm3), and
dried (Na2SO4) before concentration in vacuo. Purification by
pTLC using hexane–Me2CO (2 : 1) as eluent afforded [9-3H]-p-
coumaryl acetate (27, 8.5 mg, 44.4 lmol, 53.4 MBq mmol−1).
Chavicol (2). Chavicol (2) was prepared following the proce-
dure of Agharahimi and LeBel49 with the following modifications:
methylchavicol (1, 5 cm3, 32.6 mmol) was dissolved in CH2Cl2
(100 cm3) in an acetone–dry-ice-bath, then BBr3 (35 cm3 1 M
soln in CH2Cl2, 35 mmol) was slowly added, with the whole then
warmed to room temperature and stirred for 80 min. Next, the
solution was cooled with an ice-bath and H2O (50 cm3) was added,
with the resulting mixture extracted with CH2Cl2 (3 × 40 cm3). The
combined organic solubles were washed with brine, concentrated
in vacuo and fractionated by silica gel column chromatography
using hexane–EtOAc (9 : 1) as eluent, to afford chavicol (2, 3.71 g,
85% yield). dH (300 MHz; CDCl3; Me4Si) 7.04 (2 H, d, J2,3/5,6 8.6,
2-H/6-H), 6.77 (2 H, d, J2,3/5,6 8.6, 3-H/5-H), 5.94 (1 H, m, 8-H),
5.06 (1 H, m, 9-Ha), 5.02 (1 H, m, 9-Hb), 3.31 (2 H, d, J7,8 6.6 Hz, 7-
H); dC (75 MHz; CDCl3) 153.81 (C-4), 137.81 (C-8), 131.95 (C-1),
129.59 (C-2/C-6), 115.32 (C-9), 115.25 (C-3/C-5), 39.25 (C-7).
[9-2H2]-p-Coumaryl coumarate (32). [9-2H2]-p-Coumaryl al-
cohol (22, 203 mg, 1.34 mmol) was converted into [9-2H2]-p-
coumaryl coumarate (32, 1.17 mmol, 348.1 mg, 87% overall yield)
as described above. dH (300 MHz; Me2CO-d6; Me4Si) 7.64 (1 H,
d, J11,12 16.0 Hz, 12-H), 7.57 (2 H, d, J14,15/17,18 8.5 Hz, 14-H/18H),
7.35 (2 H, d, J2,3/5,6 8.5 Hz, 2-H/6-H), 6.90 (2 H, d, J14,15/17,18 8.5 Hz,
15-H/17-H), 6.83 (2 H, d, J2,3/5,6 8.5 Hz, 3-H/5-H), 6.68 (1 H, d,
J
7,8 15.9 Hz, 7-H), 6.39 (1 H, d, J11,12 16.0 Hz, 11-H), 6.24 (1 H, d,
J7,8 15.9 Hz, 8-H); dC (75 MHz; Me2CO-d6) 167.34 (C-10), 160.66
(C-16), 158.50 (C-4), 145.54 (C-12), 134.86 (C-7), 131.06 (C-14/C-
18), 129.06 (C-1), 128.91 (C-2/C-6), 127.10 (C-13), 121.45 (C-8),
116.76 (C-15/C-17), 116.39 (C-3/C-5), 115.64 (C-11); m/z (EI)
298 (M+, 6%), 253 (3, M − CO2), 192 (17), 164 (100, p-coumaric
acid), 147 (97), 136 (58), 134 (94), 133 (95), 120 (53, p-coumaric
acid − CO2), 119 (53), 117 (28), 107 (38), 106 (60), 105 (82), 103
(28). m/z (ESI-HRMS) 321.1025 ([M + Na] requires 321.1072).
[9-3H]-p-Coumaryl coumarate (32). [9-3H]-p-Coumaryl alco-
hol (22, 37.5 mg, 0.25 mmol) was converted into [9-3H]-p-coumaryl
coumarate (32, 45.2 mg, 0.15 mmol, 60% yield, 24.7 MBq mmol−1)
as described above.
Benzylchavicol (36). Chavicol (2, 230 mg, 1.7 mmol, 250 mm3)
and BzCl (1.6 cm3, 14 mmol) were dissolved in MeOH (20 cm3)
containing K2CO3 (4 g) and a catalytic amount of KI, and heated
until reflux began. After 25 h, the mixture was filtered, H2O
(80 cm3) was added to the filtrate and the whole extracted with
CHCl3 (3 × 100 cm3), with the combined organic solubles washed
with brine (100 cm3) and dried (Na2SO4). After concentration in
vacuo, purification with silica gel column chromatography using
CHCl3 as eluent afforded benzylchavicol (36, 168 mg, 0.75 mmol,
44% yield) as a volatile oil. dH (300 MHz; CDCl3; Me4Si) 7.35
(5 H, m, 2ꢀ-6ꢀ-H), 7.08 (2 H, d, J2,3/5,6 8.7 Hz, 2-H/6-H), 6.89 (2
H, d, J2,3/5,6 8.7 Hz, 3-H/5-H), 5.93 (1 H, m, 8-H), 5.06 (1 H, m,
9-Ha), 5.01 (1 H, m, 9-Hb), 5.00 (2 H, s, 7ꢀ-H), 3.30 (2 H, d, J7,8
6.7 Hz, 7-H); dC (75 MHz; CDCl3) 157.13 (C-4), 137.76 (C-8),
137.10 (C-1ꢀ), 132.28 (C-1), 129.46 (C-2/C-6), 128.48 (C-3ꢀ/C-5ꢀ),
127.81 (C-4ꢀ), 127.39 (C-2ꢀ/C-6ꢀ), 115.41 (C-9), 114.71 (C-3/C-5),
69.92 (C-7ꢀ), 39.30 (C-7).
p-Coumaryl acetate (27). p-Coumaryl alcohol (22, 9.4 mg,
62.7 lmol) was dissolved in pyridine (150 mm3) containing a
catalytic amount of DMAP (dimethylaminopyridine, ca. 1 mg)
and freshly distilled Ac2O (150 mm3), with the whole left unstirred
at room temperature for 3 h. Next, the mixture was added to 3%
aqueous HCl (10 cm3) and extracted with Et2O (50 cm3), with
the organic solubles washed with 3% aqueous HCl (4 × 10 cm3),
sat. NaHCO3 solution (2 × 10 cm3) and brine (10 cm3), then
dried (Na2SO4) and concentrated in vacuo. The resulting oil was
dissolved in pyrrolidine (750 mm3) and left unstirred for 10 min,
then added to 3% aqueous HCl (15 cm3), with the whole extracted
8,9-Dibromomethylchavicol (35). 8,9-Dibromomethylchavicol
(35) was prepared based on the general procedure of Berthelot
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 2733–2744 | 2741
©